Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS
Recruiting · NCT06278532 · Observational (researchers observe without assigning treatment) · Lead sponsor: Lithuanian University of Health Sciences
View the official record on ClinicalTrials.gov →Interventions studied
Brief Negative Symptoms ScaleThe Calgary Depression Scale for SchizophreniaThe Schizophrenia Cognition Rating Scale
What this trial is about
This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.
Who can take part
Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- age 18 - 65 years old;
- Diagnosis of F20, F25 or F21 according to ICD-10;
- Signed informed consent form.
Exclusion criteria
- Age younger than 18 or older than 65 years old;
- Did not sign the informed consent form;
- Legally inactive person
- Patients with a comorbid or primary diagnosis of mental retardation according to ICD-10 (F70 - F79);
- Patients with a comorbid or primary diagnosis of mental and behavioural disorders due to psychoactive substance use (F10 - F19)
- Patients with a comorbid of primary diagnosis of organic, including symptomatic, mental disorders (F00 - F09)
Where it is running
2 locations listed.
- Lithuanian University of Health Sciences Hospital Kaunas Clinics - Kaunas, Lithuania
- Jonas Montvidas - Kaunas, Lithuania